FindTrial
Sign In

Multicentre study of the incidence of GM1 and GM2 ganglioside deposition disease

Multicentre study of the morbidity of GM1 and GM2 ganglioside deposition disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047890
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ganglioside deposition disease

Interventions

GM1 group:No need
GM2 group:NO need

Sponsors

Department of Pediatrics, The Seventh Medical Center, PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. The parents read the instructions for the subjects, agreed to the treatment and signed the written informed consent; 2. Clinical diagnosis of ganglioside deposition disease.

Exclusion criteria

Exclusion criteria: Unable to comply with test requirements.

Design outcomes

Primary

MeasureTime frame
Genetic test results;—

Countries

China

Contacts

Public ContactFeng Zhichun

Department of Pediatrics, The Seventh Medical Center, PLA General Hospital

zhjfengzc@126.com+86 13321154215

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026